These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33770729)

  • 1. Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: A systematic review of preclinical evidence.
    Bayat P; Farshchi M; Yousefian M; Mahmoudi M; Yazdian-Robati R
    Int Immunopharmacol; 2021 Jun; 95():107562. PubMed ID: 33770729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
    Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
    Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis.
    Paintlia AS; Paintlia MK; Singh I; Singh AK
    Am J Pathol; 2006 Sep; 169(3):1012-25. PubMed ID: 16936274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research progress of statins on immune regulation of multiple sclerosis and experimental allergic encephalomyelitis.
    Xu D; Wang M
    Allergol Immunopathol (Madr); 2022; 50(6):76-83. PubMed ID: 36335449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
    de Toledo JHDS; Fraga-Silva TFC; Borim PA; de Oliveira LRC; Oliveira EDS; Périco LL; Hiruma-Lima CA; de Souza AAL; de Oliveira CAF; Padilha PM; Pinatto-Botelho MF; Dos Santos AA; Sartori A; Zorzella-Pezavento SFG
    Front Immunol; 2020; 11():571844. PubMed ID: 33193354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models.
    Neil S; Huh J; Baronas V; Li X; McFarland HF; Cherukuri M; Mitchell JB; Quandt JA
    Brain Behav Immun; 2017 May; 62():332-343. PubMed ID: 28238951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crotoxin down-modulates pro-inflammatory cells and alleviates pain on the MOG
    Teixeira NB; Sant'Anna MB; Giardini AC; Araujo LP; Fonseca LA; Basso AS; Cury Y; Picolo G
    Brain Behav Immun; 2020 Feb; 84():253-268. PubMed ID: 31843645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The modulatory effects of luteolin on cyclic AMP/Ciliary neurotrophic factor signaling pathway in experimentally induced autoimmune encephalomyelitis.
    El-Deeb OS; Ghanem HB; El-Esawy RO; Sadek MT
    IUBMB Life; 2019 Sep; 71(9):1401-1408. PubMed ID: 31185137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory immunotherapy for multiple sclerosis/experimental autoimmune encephalomyelitis (EAE) disease.
    Kanwar JR
    Curr Med Chem; 2005; 12(25):2947-62. PubMed ID: 16378498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total flavonoids of astragalus attenuates experimental autoimmune encephalomyelitis by suppressing the activation and inflammatory responses of microglia via JNK/AKT/NFκB signaling pathway.
    Yang L; Han X; Xing F; Wu H; Shi H; Huang F; Xu Q; Wu X
    Phytomedicine; 2021 Jan; 80():153385. PubMed ID: 33091854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis.
    Xiao J; Liu W; Chen Y; Deng W
    J Neuroinflammation; 2015 Jun; 12():117. PubMed ID: 26068104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dithiolethione ACDT suppresses neuroinflammation and ameliorates disease severity in experimental autoimmune encephalomyelitis.
    Kuo PC; Brown DA; Scofield BA; Paraiso HC; Wang PY; Yu IC; Yen JH
    Brain Behav Immun; 2018 May; 70():76-87. PubMed ID: 29604346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
    Eitan E; Hutchison ER; Greig NH; Tweedie D; Celik H; Ghosh S; Fishbein KW; Spencer RG; Sasaki CY; Ghosh P; Das S; Chigurapati S; Raymick J; Sarkar S; Chigurupati S; Seal S; Mattson MP
    Exp Neurol; 2015 Nov; 273():151-60. PubMed ID: 26277686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.
    Al-Ghezi ZZ; Miranda K; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2019; 10():1921. PubMed ID: 31497013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paricalcitol improves experimental autoimmune encephalomyelitis (EAE) by suppressing inflammation via NF-κB signaling.
    Zhang D; Qiao L; Fu T
    Biomed Pharmacother; 2020 May; 125():109528. PubMed ID: 32106388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prospects of minocycline in multiple sclerosis.
    Chen X; Ma X; Jiang Y; Pi R; Liu Y; Ma L
    J Neuroimmunol; 2011 Jun; 235(1-2):1-8. PubMed ID: 21565409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.
    Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
    Sci Rep; 2015 Nov; 5():17407. PubMed ID: 26616302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel promising therapeutic agents in multiple sclerosis.
    Mirshafiey A
    Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):218-4. PubMed ID: 19075984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spasticity Treatment Ameliorates the Efficacy of Melatonin Therapy in Experimental Autoimmune Encephalomyelitis (EAE) Mouse Model of Multiple Sclerosis.
    Ghareghani M; Zibara K; Sadeghi H; Farhadi N
    Cell Mol Neurobiol; 2018 Jul; 38(5):1145-1151. PubMed ID: 29497878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.